Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

SensiumVitals® expands distribution network

26 Mar 2014 07:00

RNS Number : 1876D
Toumaz Limited
26 March 2014
 



 

RNS REACH

26 March 2014

 

Toumaz Limited

SensiumVitals® expands international distribution network

Toumaz Limited (AIM: TMZ, 'Toumaz', or 'the Group'), a pioneer in ultra-low power wireless semiconductor technology, announces that Sensium Healthcare, its wireless healthcare division, has extended the sales reach of its SensiumVitals® vital signs monitor to 12 countries.

Sensium Healthcare has recruited its own highly experienced direct sales force in the UK, France and Germany. The company has also executed distribution agreements for another four territories in Scandinavia (Sweden, Norway and Denmark) and the Middle East (Bahrain).

Along with existing agreements in the USA, Canada, Mexico, Australia and New Zealand, SensiumVitals® now has distribution in countries which collectively account for 60% of global healthcare spend. The company has also received regulatory clearance for SensiumVitals® in Australia.

With this development of its sales and distribution networks, Sensium Healthcare is embarking on full commercialisation of the SensiumVitals® system. The company is currently in discussions with over 60 hospitals worldwide.

Anthony Sethill, CEO of Toumaz Group, said:

"In the last six months, we have established an experienced and highly effective international sales platform for SensiumVitals®.

Initial customer engagements have been very encouraging. SensiumVitals® is positioned as a "game changer" for patient safety and healthcare economics - and it is proving a compelling proposition with both clinicians and hospital managers.

In 2014, we expect a significant ramp up in Sensium Healthcare's revenues - as discussions already under way with hospitals in Europe, North America and Australia lead to deployments in all of those regions."

Enquiries:

Toumaz Limited

+44 (0)20 7391 0630

Anthony Sethill, Chief Executive Officer

Jonathan Apps, Chief Financial Officer

Instinctif Partners

+44 (0)20 7457 2056

Adrian Duffield/Rozi Morris/Kathy Gordon

About Toumaz (www.toumaz.com)

Toumaz Limited is a pioneer in low-power, wireless semiconductor and software technologies for healthcare and consumer audio. The Group has two divisions, Sensium Healthcare and Frontier Silicon. Sensium Healthcare develops wireless solutions for patient monitoring. Frontier Silicon provides chip, modules and software for digital radio and connected audio devices.

About SensiumVitals®

SensiumVitals® is an ultra-low power system for wireless monitoring of patient vital signs, including heart rate, temperature and respiration. Measurements are taken every two minutes, rather than every four to eight hours, as currently standard in general wards. Patient data is then sent wirelessly and securely to clinicians via hospital IT systems. 

The key benefit of SensiumVitals® is that it provides clinicians with rapid warnings of patient deterioration, which in turn allows for earlier interventions, shorter stays in hospital and lower healthcare costs. 

For more information, see http://www.sensium-healthcare.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRASEIFUIFLSEID
Date   Source Headline
18th Sep 20157:00 amRNSBlock Listing Interim Review
19th Aug 20157:00 amRNSTotal Voting Rights
3rd Aug 20157:00 amRNSHalf year trading update
13th Jul 20157:00 amRNSSt James's University Hospital trial
10th Jun 20157:00 amRNSCo-development agreement with Google
3rd Jun 201511:16 amRNSBoard change
29th May 20158:00 amRNSTotal Voting Rights
28th May 201510:20 amRNSResult of AGM
28th May 20157:00 amRNSTrading update
30th Apr 20158:00 amRNSTotal Voting Rights
21st Apr 20157:01 amRNSQueen Elizabeth Hospital trials SensiumVitals
21st Apr 20157:00 amRNSFull year results
1st Apr 201510:00 amRNSNotice of Results
19th Mar 20158:00 amRNSBlocklisting Interim Review
3rd Mar 20157:00 amRNSNorth American Healthcare distribution
29th Jan 20157:00 amRNSTrading update
28th Jan 20158:00 amRNSToumaz Employee Long Term Incentive Plan
28th Nov 20148:00 amRNSTotal Voting Rights
25th Sep 20147:00 amRNSHalf Yearly Report
5th Sep 20147:00 amRNSFrontier Silicon launches new digital radio module
4th Sep 20142:00 pmRNSFrontier Silicon supply agreement with Philips
27th Aug 201410:00 amRNSNotice of Results
19th Aug 20148:00 amRNSIssue of Equity
1st Aug 20147:00 amRNSTrading update
31st Jul 20148:00 amRNSTotal Voting Rights
29th Jul 20147:00 amRNSSensium awarded Technology Strategy Board funding
30th Jun 20147:00 amRNSSouth African distribution for SensiumVitals
26th Jun 20148:00 amRNSEmployee Long Term Incentive Plan
23rd May 20144:34 pmRNSResult of AGM
23rd May 20147:00 amRNSTrading Update
20th May 20147:00 amRNSFrontier Silicon gains Digital Tick Mark approval
8th May 20147:00 amRNSMiddle East distribution for SensiumVitals®
28th Apr 201410:00 amRNSIssue of Equity
14th Apr 20147:00 amRNSNew radio chip and module preview
31st Mar 20147:00 amRNSFull year results
26th Mar 20147:00 amRNSSensiumVitals® expands distribution network
24th Mar 20147:00 amRNSPioneer selects Frontier Silicon's technology
7th Mar 20142:42 pmRNSNotice of Results
31st Jan 201410:00 amRNSTotal Voting Rights
17th Jan 20147:00 amRNSYear-end trading update
16th Dec 20137:00 amRNSFrontier Silicon extends Imagination partnership
25th Nov 201310:47 amRNSResult of EGM
25th Nov 20137:00 amRNSVenice module wins industry excellence award
13th Nov 20137:00 amRNSPatrick Hannon elected President of WorldDMB
7th Nov 20137:00 amRNSPlacing
15th Oct 20137:00 amRNSSensiumVitals: CE marking & UK hospital pilot
15th Oct 20137:00 amRNSDistribution agreement: first commercial US orders
23rd Sep 20137:00 amRNSHalf Year Results
9th Sep 20137:00 amRNSSpotify Connect Agreement
5th Sep 201311:20 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.